Luminex Corporation-Company profile, Business Overview, Financial Performance, Operating Segments, Strategic Moves, and Competitive Intelligence Report

The global flow cytometry market is estimated to reach $7 billion by 2022, registering a CAGR of 16.0% over the forecast period 2014?2022. Flow cytometry is a biophysical, laser-based analytical technology that measures and analyzes several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which includes its ability to deliver precise and accurate results, and lesser time consumption at about same prices. The flow cytometry technology is widely used in various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV, and hematological malignancies. The rising count of patients suffering from HIV and cancer, and increasing use of flow cytometry in hospitals and diagnostic centers, has created an impending need for flow cytometry in the effective diagnosis as well as monitoring of diseases. The term flow cytometry as well as fluorescence-activated cell sorting are often interchangeable. FACS or fluorescence activated cell sorting used in flow cytometry have ensured a strong market future.